Artelo Biosciences Announces Closing of $3.0 Million Public Offering
1. Artelo closed a public offering of 640,924 shares at $4.40 each. 2. Total proceeds from the offering were approximately $3.0 million. 3. Underwriters have a 45-day option to purchase additional shares. 4. Artelo aims to use excess capital for digital asset investments. 5. The company has a focus on cancer and pain management therapies.